Clinical Trial Update: Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis [NA]

View source ↗

Summary

A prospective study is evaluating Teclistamab for systemic AL amyloidosis and is currently recruiting at Peking University People's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Al Amyloidosis

Drugs mentioned

• Teclistamab (teclistamab)

Snippet

Sponsor: Peking University People's Hospital | Conditions: AL Amyloidosis | NA | Status: RECRUITING